Foundayo starts at $149/month for cash-paying patients, with copays as low as $25/month with commercial insurance
Called SURMOUNT, the program is set to include four global phase 3 trials to evaluate tirzepatides safety and efficacy as an adjunct weight loss treatment in obese and overweight adults, defined as those with a BMI of 27 [6]
Some of the risk factors associated with bacterial vaginosis include (Sobel, 2020): Douching or excessive cleaning of the vagina Hormonal changes that accompany events like menstruation, pregnancy, and menopause Sex with male or female partners Presence of sexually transmitted infections, like herpes and HIV Cigarette smoking Treatments for BV The primary goal of treatment in people with BV is to relieve their symptoms
larger trials are ongoing investigating retatrutide for people with type 2 diabetes, non-alcoholic fatty liver disease, and obesity
Alternative medications may be considered if Mounjaro is discontinued but pharmacological support remains necessary
